Jiangsu Hengrui Medicine Co Ltd (600276) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.080x

Based on the latest financial reports, Jiangsu Hengrui Medicine Co Ltd (600276) has a cash flow conversion efficiency ratio of 0.080x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥4.81 Billion ≈ $703.99 Million USD) by net assets (CN¥60.03 Billion ≈ $8.78 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Jiangsu Hengrui Medicine Co Ltd worth for the company's overall valuation and market capitalisation.

Jiangsu Hengrui Medicine Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2024)

This chart illustrates how Jiangsu Hengrui Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jiangsu Hengrui Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Hengrui Medicine Co Ltd ranked by their cash flow conversion efficiency. Explore how high is Jiangsu Hengrui Medicine Co Ltd's earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Ameriprise Financial Inc
NYSE:AMP
0.074x
Quanta Computer Inc
TW:2382
-0.337x
Block, Inc
NYSE:XYZ
0.045x
Haleon plc
NYSE:HLN
0.055x
IDEXX Laboratories Inc
NASDAQ:IDXX
0.215x
Interactive Brokers Group Inc
NASDAQ:IBKR
0.279x
Flex Ltd
F:FXI
0.080x
People's Insurance of China Ltd
SHG:601319
0.073x

Annual Cash Flow Conversion Efficiency for Jiangsu Hengrui Medicine Co Ltd (1999–2024)

The table below shows the annual cash flow conversion efficiency of Jiangsu Hengrui Medicine Co Ltd from 1999 to 2024. View Jiangsu Hengrui Medicine Co Ltd stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥46.09 Billion
≈ $6.74 Billion
CN¥7.42 Billion
≈ $1.09 Billion
0.161x -13.55%
2023-12-31 CN¥41.03 Billion
≈ $6.00 Billion
CN¥7.64 Billion
≈ $1.12 Billion
0.186x +465.54%
2022-12-31 CN¥38.41 Billion
≈ $5.62 Billion
CN¥1.27 Billion
≈ $185.15 Million
0.033x -72.23%
2021-12-31 CN¥35.57 Billion
≈ $5.21 Billion
CN¥4.22 Billion
≈ $617.35 Million
0.119x +6.39%
2020-12-31 CN¥30.79 Billion
≈ $4.51 Billion
CN¥3.43 Billion
≈ $502.20 Million
0.111x -27.17%
2019-12-31 CN¥24.94 Billion
≈ $3.65 Billion
CN¥3.82 Billion
≈ $558.52 Million
0.153x +9.23%
2018-12-31 CN¥19.80 Billion
≈ $2.90 Billion
CN¥2.77 Billion
≈ $405.95 Million
0.140x -12.30%
2017-12-31 CN¥15.94 Billion
≈ $2.33 Billion
CN¥2.55 Billion
≈ $372.76 Million
0.160x -20.66%
2016-12-31 CN¥12.87 Billion
≈ $1.88 Billion
CN¥2.59 Billion
≈ $379.38 Million
0.201x -8.41%
2015-12-31 CN¥10.36 Billion
≈ $1.52 Billion
CN¥2.28 Billion
≈ $333.24 Million
0.220x +15.77%
2014-12-31 CN¥8.29 Billion
≈ $1.21 Billion
CN¥1.57 Billion
≈ $230.37 Million
0.190x -7.40%
2013-12-31 CN¥6.66 Billion
≈ $973.96 Million
CN¥1.36 Billion
≈ $199.74 Million
0.205x +16.46%
2012-12-31 CN¥5.44 Billion
≈ $796.41 Million
CN¥958.37 Million
≈ $140.24 Million
0.176x +46.20%
2011-12-31 CN¥4.38 Billion
≈ $640.72 Million
CN¥527.36 Million
≈ $77.17 Million
0.120x +8.44%
2010-12-31 CN¥3.47 Billion
≈ $508.48 Million
CN¥385.95 Million
≈ $56.48 Million
0.111x -32.59%
2009-12-31 CN¥2.67 Billion
≈ $389.98 Million
CN¥439.12 Million
≈ $64.26 Million
0.165x +183.99%
2008-12-31 CN¥2.02 Billion
≈ $296.24 Million
CN¥117.46 Million
≈ $17.19 Million
0.058x -56.71%
2007-12-31 CN¥1.63 Billion
≈ $238.99 Million
CN¥218.87 Million
≈ $32.03 Million
0.134x -36.72%
2006-12-31 CN¥1.26 Billion
≈ $183.92 Million
CN¥266.18 Million
≈ $38.95 Million
0.212x +2.98%
2005-12-31 CN¥1.11 Billion
≈ $162.15 Million
CN¥227.88 Million
≈ $33.35 Million
0.206x -1.99%
2004-12-31 CN¥998.05 Million
≈ $146.05 Million
CN¥209.41 Million
≈ $30.64 Million
0.210x +38.53%
2003-12-31 CN¥903.35 Million
≈ $132.19 Million
CN¥136.82 Million
≈ $20.02 Million
0.151x +146.17%
2002-12-31 CN¥809.97 Million
≈ $118.52 Million
CN¥49.84 Million
≈ $7.29 Million
0.062x +305.99%
2001-12-31 CN¥757.99 Million
≈ $110.92 Million
CN¥11.49 Million
≈ $1.68 Million
0.015x -48.01%
2000-12-31 CN¥672.57 Million
≈ $98.42 Million
CN¥19.61 Million
≈ $2.87 Million
0.029x -86.02%
1999-12-31 CN¥162.54 Million
≈ $23.78 Million
CN¥33.89 Million
≈ $4.96 Million
0.208x --

About Jiangsu Hengrui Medicine Co Ltd

SHG:600276 China Drug Manufacturers - Specialty & Generic
Market Cap
$40.26 Billion
CN¥275.13 Billion CNY
Market Cap Rank
#676 Global
#37 in China
Share Price
CN¥43.13
Change (1 day)
-0.05%
52-Week Range
CN¥42.67 - CN¥72.27
All Time High
CN¥193.72
About

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. It develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and… Read more